Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours (Q33751182)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours |
scientific article |
Statements
1 reference
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours (English)
1 reference
D S Boss
1 reference
G K Schwartz
1 reference
M R Middleton
1 reference
D D Amakye
1 reference
H Swaisland
1 reference
R S Midgley
1 reference
M Ranson
1 reference
S Danson
1 reference
H Calvert
1 reference
R Plummer
1 reference
C Morris
1 reference
R D Carvajal
1 reference
L R Chirieac
1 reference
J H M Schellens
1 reference
G I Shapiro
1 reference
13 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference